Blueprint: Mobile Coping Skills Training to Improve Cardiorespiratory Failure Survivors' Psychological Distress

Sponsor
Duke University (Other)
Overall Status
Completed
CT.gov ID
NCT04329702
Collaborator
National Institutes of Health (NIH) (NIH), National Heart, Lung, and Blood Institute (NHLBI) (NIH)
45
1
3
15.9
2.8

Study Details

Study Description

Brief Summary

This is a pilot randomized clinical trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is designed to test the acceptability, feasibility, and clinical impact of a coping skills training intervention (Blueprint) delivered via a mobile app. This trial will allow us to determine if new changes to intervention delivery, inclusion criteria, and other factors are successful. It will also inform the development of a next-step efficacy focused trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Coping skills training mobile app with call from CST therapist
  • Behavioral: Coping skills training mobile app only
N/A

Detailed Description

As survival has improved for the 2 million people with cardiorespiratory failure managed annually in US intensive care units (ICUs), research has clarified how these survivors suffer from severe and persistent symptoms of psychological distress-depression, anxiety, and post-traumatic stress disorder (PTSD)-after discharge. However, few interventions exist that are relevant to patients' experiences and that also accommodate their many physical, social, and financial barriers to personalized care. To fill this gap, we developed a telephone- and web-based coping skills training (CST) program.

CST is an empirically-supported psychosocial intervention that targets the use of the adaptive coping skills to decrease psychological distress and improve quality of life. We conducted a multicenter randomized clinical trial (RCT) called CSTEP that compared CST to an education program (EP) among a general sample of ICU survivors who received mechanical ventilation for cardiorespiratory failure. CST reduced depression symptoms and improved quality of life at 6 months in a pre-specified subgroup with elevated baseline distress. This RCT also identified key questions regarding best practices for identi-fying patients who are highly distressed yet whose physical illness is manageable, as well as delivering the intervention in a more convenient, and scalable manner. In a recent RCT testing a mindfulness intervention (LIFT), we found that a self-directed mobile app approach increased dose, adherence, and retention. However, many patients reported low enthusiasm for a meditation-based intervention.

What is needed before a second multicenter RCT is to apply the promising CST content to a LIFT-inspired mobile app-based delivery system, and then to test it within a targeted patient population with a high likelihood of response (i.e., high baseline psychological distress). Therefore, we propose a 2-year R34 mixed-methods project that includes a pilot RCT in which we will randomize 45 cardiorespiratory failure / insufficiency survivors to one of three arms in equal ratios: intervention plus therapist for non-responders (n ~15), intervention without a therapist (n ~15), and usual care control (n ~15). Randomization will be stratified by ICU service (medical vs. surgical), baseline HADS score (<14 vs. ≥14), and age (<50 vs. ≥50). Our specific aims will: (1) Optimize the usability of a self-directed mobile app (Blueprint) and an automated post-discharge distress screening system; (2) Test two promising iterations of Blueprint vs. usual care in a pilot 3-arm RCT with 3-month follow up, and (3) Explore facilitators and barriers to Blueprint implementation, using these data to inform any necessary final revisions to the Blueprint app.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized control clinical trialrandomized control clinical trial
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
PI and analysts blinded to allocation. Outcomes completed by participants via a mobile app and as such, outcomes assessors are blinded.
Primary Purpose:
Supportive Care
Official Title:
Optimizing a Self-directed Mobile Coping Skills Training Intervention to Improve Cardiorespiratory Failure Survivors' Psychological Distress
Actual Study Start Date :
Dec 3, 2020
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Mar 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: coping skills training plus therapist input

Participants will receive a CST therapist call within 48 hours of randomization to discuss the study rationale, to conduct a relaxation exercise, and to review app and study logistics. Participants will use the Blueprint mobile app for 1 month.

Behavioral: Coping skills training mobile app with call from CST therapist
The intervention is a mobile app that delivers a 4-week long program of coping skills training. The app contains video, visual, and text content and has a companion PDF workbook. It provides timeline-driven prompts to complete weekly tasks (e.g., viewing videos, completing surveys) and coaching participants to use their current stressors as context for real-life application of adaptive coping skills. A therapist will call participant to introduce the intervention and perform a brief relaxation exercise.
Other Names:
  • Blueprint; mobile coping skills training (mCST) plus therapist
  • Experimental: coping skills training without therapist input

    Participants will receive a call from a research coordinator to get them started with the trial. Participants will use the Blueprint mobile app for 1 month. No therapist calls will be provided. Chat room access in the app will be provided.

    Behavioral: Coping skills training mobile app only
    The intervention is a mobile app that delivers a 4-week long program of coping skills training. The app contains video, visual, and text content and has a companion PDF workbook. It provides timeline-driven prompts to complete weekly tasks (e.g., viewing videos, completing surveys) and coaching participants to use their current stressors as context for real-life application of adaptive coping skills. App chat room access will be provided.
    Other Names:
  • Blueprint; mobile coping skills training (mCST)
  • No Intervention: usual care control

    Control participants will receive the same safety oversight as intervention participants and will be provided with phone and email contacts for study staff.

    Outcome Measures

    Primary Outcome Measures

    1. Change in Hospital Anxiety and Depression Scale (HADS) questionnaire [Between baseline and 1 month post-randomization]

      Depression and anxiety symptoms. Scores range from 0 (better) to 42 (worse)

    Secondary Outcome Measures

    1. Change in Hospital Anxiety and Depression Scale (HADS) questionnaire [Between baseline and 3 months post-randomization]

      Depression and anxiety symptoms. Scores range from 0 (better) to 42 (worse)

    2. Change in Post-Traumatic Stress Symptom inventory (PTSS) [Between baseline and 1 month post-randomization]

      Post-traumatic stress disorder symptoms. Scores can range from 10 (best) to 70 (worst).

    3. Change in Post-Traumatic Stress Symptom inventory (PTSS) [Between baseline and 3 months post-randomization]

      Post-traumatic stress disorder symptoms. Scores can range from 10 (best) to 70 (worst).

    4. Client Satisfaction Questionnaire (CSQ) [1 month post-randomization]

      A measure of acceptability. Scores can range from 8 (worst) to 32 (best)

    5. Systems Usability Scale (SUS) [1 month post-randomization]

      A measure of intervention usability. Each of 10 items is scored from 1 to 5. For each of the odd numbered questions, subtract 1 from the score. For each of the even numbered questions, subtract their value from 5. Take these new values and add up the total score. Then multiply this by 2.5.Scores can range from 0 (worst) to 100 (best)

    6. Intervention adherence [1 month post-randomization]

      Quantified by number of intervention sessions, weekly surveys, and intervention

    7. Change in quality of life visual analog scale [Between baseline and 1 month post-randomization]

      A measure of quality of life. Scores can range from 0 (worst) to 100 (best)

    8. Change in quality of life visual analog scale [Between baseline and 3 month post-randomization]

      A measure of quality of life. Scores can range from 0 (worst) to 100 (best)

    9. Change in Patient Health Questionnaire 10-item scale (PHQ-10) [Between baseline and 1 month post-randomization]

      An adapted version of the PHQ-15; a measure of physical symptoms. Scores can range from 10 (best) to 20 (worst).

    10. Change in Patient Health Questionnaire 10-item scale (PHQ-10) [Between baseline and 3 months post-randomization]

      An adapted version of the PHQ-15; a measure of physical symptoms. Scores can range from 10 (best) to 20 (worst).

    11. Distress associated with depression and anxiety symptom frequency [Between baseline and 1 month post-randomization]

      A visual analog scale appended to the HADS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the HADS. Scores range from 0 (best) to 100 (worst)

    12. Distress associated with depression and anxiety symptom frequency [Between baseline and 3 months post-randomization]

      A visual analog scale appended to the HADS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the HADS. Scores range from 0 (best) to 100 (worst)

    13. Distress associated with PTSD symptom frequency [Between baseline and 1 month post-randomization]

      A visual analog scale appended to the PTSS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the PTSS. Scores range from 0 (best) to 100 (worst)

    14. Distress associated with PTSD symptom frequency [Between baseline and 3 months post-randomization]

      A visual analog scale appended to the PTSS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the PTSS. Scores range from 0 (best) to 100 (worst)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    INCLUSION CRITERIA

    1. Adult (age ≥18)

    2. Managed in a hospital setting for ≥24 hours during the time inclusion criterion #3 is met.

    3. Acute cardiorespiratory failure / insufficiency, defined as ≥1 of the following:

    • mechanical ventilation via endotracheal tube for ≥4 hours

    • non-invasive ventilation (CPAP, BiPAP) for ≥4 hours in a 24-hour period provided for acute respiratory failure

    • new use of supplemental oxygen ≥2 liters per minute (or increase in baseline continuous oxygen)

    • use of vasopressors for shock of any etiology

    • use of inotropes for shock of any etiology

    • use of pulmonary vasodilators

    • use of aortic balloon pump or cardiac assist device for cardiogenic shock

    • use of diuretic intravenous drip

    1. Cognitive status intact
    • No history of pre-existing significant cognitive impairment (e.g., dementia) as per medical chart

    • Absence of current significant cognitive impairment (impairment defined as ≥3 errors on the Callahan cognitive status screen)

    • Decisional capacity present

    1. Absence of severe and/or persistent mental illness
    • Treatment for severe and/or persistent mental illness (e.g., psychosis, bipolar affective disorder, schizoaffective disorder, schizoid personality disorder, schizophrenia [as per medical record], hospitalization for any psychiatric disorder) within the 6 months preceding the current hospital admission

    • No endorsement of active suicidality at time of admission or informed consent

    • No active substance abuse at a severity that impairs ability to participate

    1. Functional English fluency
    EXCLUSION CRITERIA (in hospital):
    1. Complex medical care expected soon after discharge (e.g., planned surgeries, transplantation evaluation, extensive travel needs for follow up care, disruptive chemotherapy/radiation regimen)

    2. Unable to complete study procedures as determined by staff

    3. Lack of access to either reliable smartphone with cellular data plan or wifi

    INCLUSION CRITERIA (post-discharge)

    1. Elevated baseline (T1) psychological distress symptoms, defined as HADS total score of ≥8

    EXCLUSION CRITERIA (post-discharge)

    1. Failure to randomize within 2 months post-discharge.

    2. Failure to access app within 1 month after randomization in the absence of other explanation (e.g., hospitalization).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Duke University Medical Center Durham North Carolina United States 27710

    Sponsors and Collaborators

    • Duke University
    • National Institutes of Health (NIH)
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Christopher E Cox, MD, Duke University

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Duke University
    ClinicalTrials.gov Identifier:
    NCT04329702
    Other Study ID Numbers:
    • Pro00101848
    • 1R34HL145387
    First Posted:
    Apr 1, 2020
    Last Update Posted:
    Jun 3, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Duke University

    Study Results

    No Results Posted as of Jun 3, 2022